Mirae Asset Global Investments Co., Ltd.
Position in PYXS — Pyxis Oncology, Inc.
CIK 1569395
SEOUL, M5
Position in PYXS
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$4,742
+$1,263 QoQ
Shares Held
3,248
+7.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 78 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PYXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Mirae Asset Global Investments Co., Ltd. holds $260,108,715 across 206 Biotechnology names. PYXS ranks #203 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
188,064 | $83,978,097 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
84,608 | $65,371,524 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
40,926 | $21,423,530 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
56,391 | $18,658,089 | |
| 5 | INSM |
INSMED Inc
|
92,080 | $15,056,920 | |
| 6 | ONC |
BeOne Medicines Ltd.
|
23,740 | $7,050,067 | |
| 7 | RPRX |
Royalty Pharma plc
|
146,024 | $7,004,771 | |
| 8 | INCY |
Incyte Corp
|
47,258 | $4,447,922 |
All Filings in PYXS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,742 | 3,248 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $3,479 | 3,026 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $5,323 | 2,398 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $2,632 | 2,393 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $1,950 | 1,990 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $3,091 | 1,982 | Shares | Sole | 2025-01-27 | |
| No filing history on record for this holder in this stock. | ||||||